Table 5.
Feature tracking and haemodynamic forces analysis comparing patient with vs. without adverse remodelling
| STEMI, n = 49 | |||
|---|---|---|---|
| Adverse remodelling, n = 18 (37%) | Non‐adverse remodelling, n = 31 (63%) | P | |
| Feature tracking analysis | |||
| GLS‐endo (%) | −13 ± 5 | −15 ± 5 | 0.308 |
| GLS‐myo (%) | −13 ± 5 | −12 ± 8 | 0.782 |
| GCS‐endo (%) | −25 ± 5 | −25 ± 6 | 0.782 |
| GCS‐myo (%) | −17 ± 4 | −18 ± 4 | 0.494 |
| GRS (%) | 46 ± 15 | 49 ± 15 | 0.811 |
| Haemodynamic forces: entire heart cycle | |||
| A‐B (%) | 12 ± 4 | 14 ± 5 | 0.308 |
| L‐S (%) | 2.2 ± 0.5 | 2.6 ± 0.7 | 0.212 |
| L‐S/A‐B HDFs ratio (%) | 19 ± 6 | 19 ± 4 | 0.645 |
| Angle φ (°) | 74 ± 3 | 74 ± 2 | 0.726 |
| Haemodynamic forces entire: systole | |||
| A‐B (%) | 18 ± 5 | 21 ± 6 | 0.213 |
| L‐S (%) | 2.7 ± 0.9 | 3.6 ± 1 | 0.027 |
| L‐S/A‐B HDFs ratio (%) | 15 ± 4 | 18 ± 5 | 0.141 |
| Impulse angle φ (°) | 76 ± 3 | 75 ± 3 | 0.291 |
| Haemodynamic forces entire: diastole | |||
| A‐B (%) | 8 ± 7 | 9 ± 7 | 0.567 |
| L‐S (%) | 1.9 ± 0.8 | 1.7 ± 1 | 0.187 |
| L‐S/A‐B HDFs ratio (%) | 28 ± 14 | 19 ± 6 | 0.030 |
| Impulse angle φ (°) | 71 ± 7 | 75 ± 4 | 0.03 |
A‐B, apex‐base; GCS‐endo, endocardial global circumferential strain; GCS‐myo, transmural global circumferential strain; GLS‐endo, endocardial global longitudinal strain; GLS‐myo, transmural global longitudinal strain; GRS, global radial strain; HDFs, haemodynamic forces; L‐S, latero‐septal; STEMI, segment elevation myocardial infarction.